rs140777637

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6BP7BS2

The NM_001353921.2(ARHGEF9):​c.675G>A​(p.Gln225Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00041 in 1,202,473 control chromosomes in the GnomAD database, including 1 homozygotes. There are 173 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00038 ( 0 hom., 11 hem., cov: 23)
Exomes 𝑓: 0.00041 ( 1 hom. 162 hem. )

Consequence

ARHGEF9
NM_001353921.2 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: 2.95

Publications

0 publications found
Variant links:
Genes affected
ARHGEF9 (HGNC:14561): (Cdc42 guanine nucleotide exchange factor 9) The protein encoded by this gene is a Rho-like GTPase that switches between the active (GTP-bound) state and inactive (GDP-bound) state to regulate CDC42 and other genes. This brain-specific protein also acts as an adaptor protein for the recruitment of gephyrin and together these proteins facilitate receceptor recruitement in GABAnergic and glycinergic synapses. Defects in this gene are the cause of startle disease with epilepsy (STHEE), also known as hyperekplexia with epilepsy, as well as several other types of cognitive disability. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
ARHGEF9 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 8
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant X-63678480-C-T is Benign according to our data. Variant chrX-63678480-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 128451.
BP7
Synonymous conserved (PhyloP=2.95 with no splicing effect.
BS2
High Hemizygotes in GnomAd4 at 11 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARHGEF9NM_001353921.2 linkc.675G>A p.Gln225Gln synonymous_variant Exon 5 of 10 ENST00000671741.2 NP_001340850.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARHGEF9ENST00000671741.2 linkc.675G>A p.Gln225Gln synonymous_variant Exon 5 of 10 NM_001353921.2 ENSP00000500715.1

Frequencies

GnomAD3 genomes
AF:
0.000377
AC:
42
AN:
111391
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000326
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000956
Gnomad ASJ
AF:
0.00416
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00418
Gnomad NFE
AF:
0.000527
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000459
AC:
77
AN:
167935
AF XY:
0.000584
show subpopulations
Gnomad AFR exome
AF:
0.0000827
Gnomad AMR exome
AF:
0.000114
Gnomad ASJ exome
AF:
0.00348
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000424
Gnomad OTH exome
AF:
0.00212
GnomAD4 exome
AF:
0.000413
AC:
451
AN:
1091032
Hom.:
1
Cov.:
30
AF XY:
0.000453
AC XY:
162
AN XY:
357448
show subpopulations
African (AFR)
AF:
0.000304
AC:
8
AN:
26339
American (AMR)
AF:
0.000173
AC:
6
AN:
34636
Ashkenazi Jewish (ASJ)
AF:
0.00375
AC:
72
AN:
19221
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30049
South Asian (SAS)
AF:
0.000512
AC:
27
AN:
52742
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
39989
Middle Eastern (MID)
AF:
0.00606
AC:
25
AN:
4123
European-Non Finnish (NFE)
AF:
0.000329
AC:
276
AN:
838130
Other (OTH)
AF:
0.000808
AC:
37
AN:
45803
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
18
36
55
73
91
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000377
AC:
42
AN:
111441
Hom.:
0
Cov.:
23
AF XY:
0.000327
AC XY:
11
AN XY:
33627
show subpopulations
African (AFR)
AF:
0.0000326
AC:
1
AN:
30693
American (AMR)
AF:
0.0000955
AC:
1
AN:
10472
Ashkenazi Jewish (ASJ)
AF:
0.00416
AC:
11
AN:
2645
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3525
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2589
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5982
Middle Eastern (MID)
AF:
0.00459
AC:
1
AN:
218
European-Non Finnish (NFE)
AF:
0.000527
AC:
28
AN:
53127
Other (OTH)
AF:
0.00
AC:
0
AN:
1506
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00135
Hom.:
8
Bravo
AF:
0.000385

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Apr 03, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ARHGEF9: BP4, BP7, BS2 -

Jun 04, 2013
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Nov 28, 2016
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

ARHGEF9-related disorder Benign:1
Sep 17, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Inborn genetic diseases Benign:1
Nov 24, 2014
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Developmental and epileptic encephalopathy, 8 Benign:1
Dec 19, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.47
CADD
Benign
7.4
DANN
Benign
0.74
PhyloP100
3.0
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140777637; hg19: chrX-62898360; API